TurCDubessyALOtero-RomeroS, et al. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. Mult Scler2022; 28(9): 1424–1456.
2.
Otero-RomeroSLebrun-FrénayCReyesS, et al. ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. Mult Scler2023; 29(8): 904–925.
3.
DohertyTMDel GiudiceGMaggiS. Adult vaccination as part of a healthy lifestyle: Moving from medical intervention to health promotion. Ann Med2019; 51(2): 128–140.
4.
ReyesSRamsayMLadhaniS, et al. Protecting people with multiple sclerosis through vaccination. Pract Neurol2020; 20(6): 435–445.
5.
ReyesSCunninghamALKalincikT, et al. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement. J Neuroimmunol2021; 357: 577627.
6.
GroenewegLLoeffenYGTVersluysAB, et al. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients. Vaccine2021; 39: 3338–3345.
7.
Piché-RenaudP-PYue LeeEJiC, et al. Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: A systematic review and meta-analysis. Am J Transplant. Epub ahead of print 13 June 2023. DOI: 10.1016/j.ajt.2023.06.008.
8.
Danziger-IsakovLKumarD and AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant2019; 33(9): e13563.
9.
LapucciCBocciaVDSiritoT, et al. R2—Safety of anti-Varicella Zoster Virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series. Mult Scler2023; 29(11-12): 1514-1517.
10.
PaybastSSahraianMANahayatiMA, et al. Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature. Mult Scler Relat Disord2023; 77: 104793.
